At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BIB ProShares Ultra Nasdaq Biotechnology
Trading 08-31 11:48:45 EDT
115.53
-0.86
-0.74%
High116.27Low113.31Vol5.55K
Open116.20D1 Closing116.39Amplitude2.54%
Mkt Cap100.51MTradable Cap100.51MTotal Shares870.00K
T/O637.14KT/O Rate0.64%Tradable Shares870.00K
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Political and General News Events from August 31
Reuters  ·  21:15
Political and General News Events from August 31
Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients
MT Newswires Live  ·  17:51
Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients
Amgen Repatha reduces risk of death in high-risk adults for first heart attack
TIPRANKS  ·  17:10
Amgen Repatha reduces risk of death in high-risk adults for first heart attack
Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke
THOMSON REUTERS  ·  15:18
Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke
Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run
Simply Wall St.  ·  08-30 07:30
Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run
Crinetics Shareholders Approve Vertex Acquisition at Special Meeting
TIPRANKS  ·  08-29 05:33
Crinetics Shareholders Approve Vertex Acquisition at Special Meeting
Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors
Dow Jones  ·  08-29 04:35
Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors
Amgen Inc. Stock Underperforms Friday When Compared to Competitors
Dow Jones  ·  08-29 04:34
Amgen Inc. Stock Underperforms Friday When Compared to Competitors
Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo
TIPRANKS  ·  08-29 01:20
Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo
Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors
TIPRANKS  ·  08-29 00:30
Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors
Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors
TIPRANKS  ·  08-29 00:30
Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors
Political and General News Events from August 28
Reuters  ·  08-28
Political and General News Events from August 28
Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push
Reuters  ·  08-28
Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push
Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares
Reuters  ·  08-28
Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares
Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV
TIPRANKS  ·  08-28
Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV
US FDA Approves Gilead's Once-Daily Combination Pill for HIV Treatment
Reuters  ·  08-28
US FDA Approves Gilead's Once-Daily Combination Pill for HIV Treatment
U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults with Hiv, Including Those on Complex Regimens
THOMSON REUTERS  ·  08-28
U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults with Hiv, Including Those on Complex Regimens
Moderna Inc. Stock Slips 4.6%, Underperforms Peers
Dow Jones  ·  08-28
Moderna Inc. Stock Slips 4.6%, Underperforms Peers
Amgen’s AMG 691 Phase 1 Trial Targets Key Growth in Asian Markets
TIPRANKS  ·  08-28
Amgen’s AMG 691 Phase 1 Trial Targets Key Growth in Asian Markets
Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and Amgen (AMGN)
TIPRANKS  ·  08-27
Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and Amgen (AMGN)

Introduction

Company Name.
ProShares Ultra Nasdaq Biotechnology
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
Issue price:
--